<?xml version="1.0" encoding="UTF-8"?>
<p>Calcium channel blockers (CCBs) reduce the intracellular Ca
 <sup>2+</sup> level and are widely used for treating various cardiovascular diseases, including hypertension, angina, and supraventricular arrhythmias. Recently, the antiviral activity of CCBs against ebolavirus (Sakurai et al., 
 <xref rid="B52" ref-type="bibr">2015</xref>), marburgvirus (Dewald et al., 
 <xref rid="B13" ref-type="bibr">2018</xref>), Jun√≠n virus (Lavanya et al., 
 <xref rid="B35" ref-type="bibr">2013</xref>), West Nile virus (Scherbik and Brinton, 
 <xref rid="B54" ref-type="bibr">2010</xref>), and Japanese encephalitis virus (Wang et al., 
 <xref rid="B69" ref-type="bibr">2017</xref>) has been reported.
</p>
